Vaso Corporation revenue by segment VASO

Annual Quarterly

Vaso Corporation splits its revenue 2 ways in its filings. By operating segments, the largest line in Q2 of fiscal 2026, the quarter ended Jun 30, 2026 was Professional Sales Service Segments at $10.5 million, 94% of the total. By sales mix, the largest line in Q2 of fiscal 2026, the quarter ended Jun 30, 2026 was Professional Sales Services at $10.5 million, 94% of the total.

USD in millions. The percent under a figure is the change from the same quarter a year earlier.

Line	TTM Jun 30, 2026	Q2 FY2026 Jun 30, 2026	Q1 FY2026 Mar 31, 2026	Q4 FY2025 Dec 31, 2025	Q3 FY2025 Sep 30, 2025	Q2 FY2025 Jun 30, 2025	Q1 FY2025 Mar 31, 2025	Q4 FY2024 Dec 31, 2024	Q3 FY2024 Sep 30, 2024
Revenue	90	11	19	27	23	20	19	27	21
Operating segments
Professional Sales Service Segments	—	10 +20.0% share 93.8%	9 +6.1% share 47.7%	16 +6.3% share 58.9%	11 +18.7% share 47.8%	9 share 43.8%	9 share 44.7%	15 share 55.4%	9 share 43.9%
Equipment Segments	—	1 +31.0% share 6.2%	1 +26.7% share 2.9%	1 -7.6% share 3.1%	1 +8.0% share 2.7%	1 share 2.7%	0 share 2.3%	1 share 3.4%	1 share 2.8%
Sales mix
Professional Sales Services	—	10 +20.0% share 93.8%	9 +6.1% share 47.7%	16 +6.3% share 58.9%	11 +18.7% share 47.8%	9 share 43.8%	9 share 44.7%	15 share 55.4%	9 share 43.9%
Medical Equipment Sales	—	1 +33.1% share 5.9%	1 +28.6% share 2.7%	1 -7.9% share 3.0%	1 +8.5% share 2.6%	0 share 2.5%	0 share 2.1%	1 share 3.3%	1 share 2.6%
Medical Equipment Service	—	0 -3.2% share 0.3%	0 +0.0% share 0.2%	0 +0.0% share 0.1%	0 +0.0% share 0.1%	0 share 0.2%	0 share 0.2%	0 share 0.1%	0 share 0.1%

How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry: Electromedical & Electrotherapeutic Apparatus (SIC 3845)
Listed as: VASO (OTC)
Fiscal year ends: December 31
Incorporated in: DE
Headquarters: Plainview, NY
SEC filer status: Non-accelerated filer, Smaller reporting company
SEC CIK: 839087
Former names: VASOMEDICAL, INC (until Sep 23, 2016); VASOMEDICAL INC (until May 15, 2012)

Other Electromedical & Electrotherapeutic Apparatus companies

All 31 Electromedical & Electrotherapeutic Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.